Related references
Note: Only part of the references are listed.Topical calcineurin inhibitors compromise stratum corneum integrity, epidermal permeability and antimicrobial barrier function
Minjeong Kim et al.
EXPERIMENTAL DERMATOLOGY (2010)
ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis
U. Darsow et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2010)
Skin physiological parameters confirm the therapeutic efficacy of pimecrolimus cream 1% in patients with mild-to-moderate atopic dermatitis
Roland Aschoff et al.
EXPERIMENTAL DERMATOLOGY (2009)
Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitis (Reprinted from J Allergy Clin Immunol vol 123, pg 1124-33, 2009)
Jens-Michael Jensen et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
A randomized controlled trial of pimecrolimus cream 1% in adolescents and adults with head and neck atopic dermatitis and intolerant of, or dependent on, topical corticosteroids
D. F. Murrell et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Evaluation of the atrophogenic potential of different glucocorticoids using optical coherence tomography, 20-MHz ultrasound and profilometry; a double-blind, placebo-controlled trial
M. Cossmann et al.
BRITISH JOURNAL OF DERMATOLOGY (2006)
The burden of atopic dermatitis: Impact on the patient, family, and society
CL Carroll et al.
PEDIATRIC DERMATOLOGY (2005)
Long-term control of atopic dermatitis with pimecrolimus cream 1% in infants and young children:: A two-year study
KA Papp et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2005)
Pimecrolimus - an anti-inflammatory drug targeting the skin
M Grassberger et al.
EXPERIMENTAL DERMATOLOGY (2004)
Impaired sphingomyelinase activity and epidermal differentiation in atopic dermatitis
JM Jensen et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2004)
Pimecrolimus: A review
AK Gupta et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2003)
Topical pimecrolimus - A review of its clinical potential in the management of atopic dermatitis
K Wellington et al.
DRUGS (2002)
Quantification of corticosteroid-induced skin vasoconstriction: visual ranking, chromameter measurement or digital imaging analysis
EW Smith et al.
DERMATOLOGY (2002)
Pimecrolimus cream in the long-term management of atopic dermatitis in adults: A six-month study
M Meurer et al.
DERMATOLOGY (2002)
Different skin thinning potential of equipotent medium-strength glucocorticoids
HC Korting et al.
SKIN PHARMACOLOGY AND APPLIED SKIN PHYSIOLOGY (2002)
Corticosteroid-induced atrophy and barrier impairment measured by non-invasive methods in human skin
L Kolbe et al.
SKIN RESEARCH AND TECHNOLOGY (2001)
The new topical ascomycin derivative SDZ ASM 981 does not induce skin atrophy when applied to normal skin for 4 weeks: a randomized, double-blind controlled study
C Queille-Roussel et al.
BRITISH JOURNAL OF DERMATOLOGY (2001)
Optical coherence tomography in dermatology: a review
J Welzel
SKIN RESEARCH AND TECHNOLOGY (2001)
In vivo optical coherence tomography imaging of human skin: norm and pathology
ND Gladkova et al.
SKIN RESEARCH AND TECHNOLOGY (2000)
Share Paper
